Geran Davies
Corporate Officer/Principal chez The Chartered Quality Institute
Profil
Geran Davies is currently a Member at The Chartered Quality Institute.
Previously, he worked as Head-Quality at BBI Diagnostics Group Ltd.
Postes actifs de Geran Davies
| Sociétés | Poste | Début |
|---|---|---|
| The Chartered Quality Institute | Corporate Officer/Principal | - |
Anciens postes connus de Geran Davies
| Sociétés | Poste | Fin |
|---|---|---|
BBI Diagnostics Group Ltd.
 BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
BBI Diagnostics Group Ltd.
BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
| The Chartered Quality Institute |
